Profile | GDS2987 / GI_37675278-I |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 20.9 | 56 |
GSM215244 | HMVEC_vehicle_rep2 | 9 | 23 |
GSM215253 | HMVEC_vehicle_rep3 | 6.6 | 22 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 40.2 | 60 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 1.5 | 2 |
GSM215294 | HMVEC_SLx2119_rep1 | 17.7 | 52 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 29.7 | 45 |
GSM215297 | PASMC_vehicle_rep1 | 23.7 | 35 |
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | 18.8 | 30 |
GSM215311 | PASMC_atorvastatin_rep1 | 13.8 | 24 |
GSM215312 | PASMC_atorvastatin_rep2 | 14.5 | 23 |
GSM215313 | PASMC_atorvastatin_rep3 | 41.6 | 52 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 15.7 | 26 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 7 | 14 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 4.1 | 8 |
GSM215329 | PASMC_SLx2119_rep3 | 18.1 | 34 |
GSM215330 | Fibroblasts_vehicle_rep1 | 4.6 | 11 |
GSM215331 | Fibroblasts_vehicle_rep2 | 15.1 | 40 |
GSM215332 | Fibroblasts_vehicle_rep3 | 21.9 | 55 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 10.2 | 28 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 35.2 | 60 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 18.6 | 51 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 32.8 | 64 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 12.2 | 33 |
GSM215339 | Fibroblasts_SLx2119_rep1 | ||
GSM215340 | Fibroblasts_SLx2119_rep2 | 16.1 | 41 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 0.1 | 0 |